Tang Capital Management LLC Adaptimmune Therapeutics PLC Transaction History

Tang Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.83 - $1.47 $249,000 - $441,000	300,000 Added 20.78%	1,743,619 $1.71 Million
Q1 2024 May 15, 2024	SELL	$0.7 - $1.75 $2.06 Million - $5.15 Million	-2,943,619 Reduced 67.1%	1,443,619 $2.28 Million
Q4 2023 Feb 14, 2024	SELL	$0.43 - $0.79 $215,000 - $395,000	-500,000 Reduced 10.23%	4,387,238 $3.47 Million
Q2 2023 Aug 14, 2023	BUY	$0.9 - $1.51 $4.4 Million - $7.38 Million	4,887,238 New	4,887,238 $4.5 Million

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $98M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.